A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of tadalafil when given to
men who are currently taking a medication called an alpha blocker for the treatment of benign
prostatic hyperplasia (BPH) symptoms (such as urinary frequency, urgency, and a feeling that
the bladder is not completely emptied after urination).